Headlines about prescription drug sticker-shock miss the real problem: Specialty pharmacy rules, PBM incentives, and opaque contracting are determining access and out-of-pocket costs in a system that ...
Growing regulatory scrutiny and industry reporting suggests that high drug prices persist not just because of cost, but because of a system designed to protect pricing benchmarks, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results